Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Goodwill & Intangibles (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Goodwill & Intangibles data on record, last reported at $19.3 million in Q4 2025.

  • For Q4 2025, Goodwill & Intangibles changed 0.0% year-over-year to $19.3 million; the TTM value through Dec 2025 reached $19.3 million, changed 0.0%, while the annual FY2025 figure was $19.3 million, 0.0% changed from the prior year.
  • Goodwill & Intangibles reached $19.3 million in Q4 2025 per CAI's latest filing, roughly flat from $19.3 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $19.3 million in Q4 2024 and bottomed at $19.3 million in Q4 2024.